Literature DB >> 23462994

Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.

Xingwu Wang1, Meng Zha, Xiaocheng Zhao, Peng Jiang, Wenjing Du, Andrew Y H Tam, Yide Mei, Mian Wu.   

Abstract

The tumour suppressor alternative reading frame (ARF) is one of the most frequently mutated proteins in human cancer. It has been well established that ARF is able to stabilize and activate p53 by directly inhibiting Mdm2. ARF-mediated p53 activation in response to oncogenic stress is thought to be an important determinant of protection against cancer. However, little is known regarding the control of ARF in cells. Here, we show that Siva1 is a specific E3 ubiquitin ligase of ARF. Siva1 physically interacts with ARF both in vitro and in vivo. Through direct interaction, Siva1 promotes the ubiquitination and degradation of ARF, which in turn affects the stability of p53. Functionally, Siva1 regulates cell cycle progression and cell proliferation in an ARF/p53-dependent manner. Our results uncover a novel regulatory mechanism for the control of ARF stability, thereby revealing an important function of Siva1 in the regulation of the ARF-Mdm2-p53 pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462994     DOI: 10.1038/ncomms2533

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  38 in total

1.  The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.

Authors:  Andre Fortin; Jason G MacLaurin; Nicole Arbour; Sean P Cregan; Neena Kushwaha; Steven M Callaghan; David S Park; Paul R Albert; Ruth S Slack
Journal:  J Biol Chem       Date:  2004-04-22       Impact factor: 5.157

2.  RUVBL2 is a novel repressor of ARF transcription.

Authors:  Chongwei Xie; Wenyu Wang; Fan Yang; Mian Wu; Yide Mei
Journal:  FEBS Lett       Date:  2012-01-26       Impact factor: 4.124

Review 3.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

4.  The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis.

Authors:  Peng Jiang; Wenjing Du; Klaus Heese; Mian Wu
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

Review 5.  Tumor surveillance via the ARF-p53 pathway.

Authors:  C J Sherr
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

6.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

7.  Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.

Authors:  Neshat Saadatmandi; Traci Tyler; Yinghui Huang; Ali Haghighi; Greg Frost; Per Borgstrom; Ruth A Gjerset
Journal:  Cancer Gene Ther       Date:  2002-10       Impact factor: 5.987

8.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.

Authors:  D E Quelle; F Zindy; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

9.  p53-independent apoptosis is induced by the p19ARF tumor suppressor.

Authors:  Keitaro Tsuji; Kiyohisa Mizumoto; Haruka Sudo; Keisuke Kouyama; Etsuro Ogata; Masaaki Matsuoka
Journal:  Biochem Biophys Res Commun       Date:  2002-07-19       Impact factor: 3.575

10.  Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.

Authors:  Philipp G Hemmati; Bernhard Gillissen; Clarissa von Haefen; Jana Wendt; Lilian Stärck; Dilek Güner; Bernd Dörken; Peter T Daniel
Journal:  Oncogene       Date:  2002-05-09       Impact factor: 9.867

View more
  32 in total

Review 1.  DNA repair pathways and their roles in drug resistance for lung adenocarcinoma.

Authors:  Altan Kara; Aykut Özgür; Sinem Nalbantoğlu; Abdullah Karadağ
Journal:  Mol Biol Rep       Date:  2021-04-15       Impact factor: 2.316

2.  Aberrant Expression of p14ARF in Human Cancers: A New Biomarker?

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Tumor Microenviron       Date:  2019-02-04

3.  The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.

Authors:  Jeanine L Van Nostrand; Alice Brisac; Stephano S Mello; Suzanne B R Jacobs; Richard Luong; Laura D Attardi
Journal:  Cancer Discov       Date:  2015-03-26       Impact factor: 39.397

4.  RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription.

Authors:  Fang Wang; Kailiang Zhao; Sixiang Yu; An Xu; Wei Han; Yide Mei
Journal:  J Biol Chem       Date:  2018-11-09       Impact factor: 5.157

5.  Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.

Authors:  Kailiang Zhao; Yang Yang; Guang Zhang; Chenfeng Wang; Decai Wang; Mian Wu; Yide Mei
Journal:  EMBO Rep       Date:  2018-01-02       Impact factor: 8.807

6.  Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF.

Authors:  Su Yeon Han; Aram Ko; Haruhisa Kitano; Chel Hun Choi; Min-Sik Lee; Jinho Seo; Junya Fukuoka; Soo-Youl Kim; Stephen M Hewitt; Joon-Yong Chung; Jaewhan Song
Journal:  Cancer Res       Date:  2016-10-28       Impact factor: 12.701

7.  Siva plays a critical role in mouse embryonic development.

Authors:  Suzanne B R Jacobs; Jeanine L Van Nostrand; Margot E Bowen; Julie C Baker; Laura D Attardi
Journal:  Cell Death Differ       Date:  2019-06-04       Impact factor: 15.828

8.  E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia.

Authors:  I-K Park; W Blum; S D Baker; M A Caligiuri
Journal:  Leukemia       Date:  2016-10-24       Impact factor: 11.528

9.  A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding.

Authors:  Jodie N Painter; Susanne Kaufmann; Tracy A O'Mara; Kristine M Hillman; Haran Sivakumaran; Hatef Darabi; Timothy H T Cheng; John Pearson; Stephen Kazakoff; Nicola Waddell; Erling A Hoivik; Ellen L Goode; Rodney J Scott; Ian Tomlinson; Alison M Dunning; Douglas F Easton; Juliet D French; Helga B Salvesen; Pamela M Pollock; Deborah J Thompson; Amanda B Spurdle; Stacey L Edwards
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

10.  S6 Kinase- and β-TrCP2-Dependent Degradation of p19Arf Is Required for Cell Proliferation.

Authors:  Tadashi Nakagawa; Takaaki Araki; Makiko Nakagawa; Atsushi Hirao; Michiaki Unno; Keiko Nakayama
Journal:  Mol Cell Biol       Date:  2015-08-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.